Midatech Pharma US Inc. 4
4 · Midatech Pharma US Inc. · Filed Dec 7, 2015
Insider Transaction Report
Form 4
Richardson Paul John
Director
Transactions
- Disposition to Issuer
Stock Option
2015-12-04−12,000→ 0 totalExercise: $3.75From: 2014-05-10Exp: 2023-05-10→ Common Stock (12,000 underlying) - Disposition to Issuer
Stock Option
2015-12-04−32,000→ 0 totalExercise: $0.79From: 2015-02-09Exp: 2025-02-09→ Common Stock (32,000 underlying) - Disposition to Issuer
Stock Option
2015-12-04−1,733→ 0 totalExercise: $5.05From: 2013-05-10Exp: 2023-02-28→ Common Stock (1,733 underlying) - Disposition to Issuer
Stock Option
2015-12-04−10,000→ 0 totalExercise: $5.05From: 2015-12-04Exp: 2023-02-28→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option
2015-12-04−38,462→ 0 totalExercise: $1.17From: 2015-05-19Exp: 2024-05-19→ Common Stock (38,462 underlying) - Disposition to Issuer
Stock Option
2015-12-04−21,739→ 0 totalExercise: $0.69From: 2015-09-19Exp: 2025-05-19→ Common Stock (21,739 underlying) - Disposition to Issuer
Stock Option
2015-12-04−10,901→ 0 totalExercise: $0.86From: 2015-11-15Exp: 2025-09-01→ Common Stock (10,901 underlying)
Footnotes (1)
- [F1]In connection with the closing of the Agreement and Plan of Merger among DARA BioSciences, Inc. (DARA), Midatech Pharma PLC (Midatech) and certain other parties thereto, these options were assumed by Midatech and replaced with options to purchase 0.136 Midatech American Depository Receipts (Midatech ADRs) for each DARA option held, at an exercise price equal to the exercise price of the applicable DARA option divided by 0.136. Each Midatech ADR represents two Midatech ordinary shares.